Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
RLS/P On Other Exchanges
Symbol
Exchange
Venture
All times are local (Market data is delayed by at least 15 minutes).

royal lifescience corp (RLS/P) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ROYAL LIFESCIENCE CORP (RLS/P)

Related News

No related news articles were found.

royal lifescience corp (RLS/P) Related Businessweek News

No Related Businessweek News Found

royal lifescience corp (RLS/P) Details

Royal Lifescience Corp. does not have significant operations. It intends to identify and evaluate assets and businesses to complete a qualifying transaction. The company was founded in 2011 and is headquartered in Vancouver, Canada.

Founded in 2011

royal lifescience corp (RLS/P) Top Compensated Officers

Chief Executive Officer, Chief Financial Offi...
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

royal lifescience corp (RLS/P) Key Developments

Royal Lifescience Corp. Announces Executive Changes

Royal Lifescience Corp. at its annual and special general meeting of shareholders held on April 28, 2015, the company's shareholders elected Pradeep Varshney as director of the company. Mr. Kehong Wu was not nominated for the re-election. Mr. Varshney is an accountant with current and past experience working with listed companies on the TSX Venture Exchange.

Royal Lifescience Corp., Annual General Meeting, Apr 28, 2015

Royal Lifescience Corp., Annual General Meeting, Apr 28, 2015., at 10:00 Pacific Standard Time. Location: 1780­400 Burrard Street. Agenda: To receive and consider the audited financial statements of the company for the most recently completed financial year ended September 30, 2014 together with the auditor's report thereon; to appoint MNP LLP, Chartered Accountants, as auditors for the company for the ensuing year and to authorize the directors of the company to fix the remuneration to be paid to the auditors; to set the number of directors of the company for the ensuring year at three persons; to elect the directors of the company to hold office until the next annual general meeting of the company, or until such time as their successors are duly elected or appointed in accordance with the company’s constating documents to consider, and if thought appropriate, to amend the existing 10% rolling Option Plan; and to transact such other business as may properly come before the Meeting and any adjournment thereof.

Royal Lifescience Corp. Auditor Raises 'Going Concern' Doubt

Royal Lifescience Corp. filed its Annual on Jan 28, 2015 for the period ending Sep 30, 2014. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RLS/P:CN C$0.00 CAD 0.00

RLS/P Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RLS/P.
View Industry Companies
 

Industry Analysis

RLS/P

Industry Average

Valuation RLS/P Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROYAL LIFESCIENCE CORP, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.